OnDemand: Ask the Researchers: Drs. Nikhil Dhurandhar and Leah Whigham on Practical Obesity Management-2024_Aug_Ask_the_Researchers_ACCME

2024_Aug_Ask_the_Researchers_ACCME_Info

Pdf Summary

This document is the front matter for an August 2024 Obesity Society CME course titled “Ask the Researchers: Drs. Nikhil Dhurandhar and Leah Whigham on Practical Obesity Management.” It provides accreditation details for both live and on-demand formats, each offering up to 1 AMA PRA Category 1 Credit, with the note that combined credit across formats cannot exceed 1. The on-demand version was released September 1, 2024 and will remain available until December 31, 2026.<br /><br />The course has two learning objectives: to describe research aimed at streamlining obesity management in primary care, and to explain how primary care providers can use that research to improve obesity care in their own practices. The activity received no commercial support.<br /><br />The document also includes CME disclosure and integrity statements. The Obesity Society says it follows ACCME standards, requires disclosure of financial relationships with ineligible companies, and mitigates conflicts before the activity begins. Speaker disclosures indicate that Drs. Dhurandhar and Whigham had no relevant financial relationships. Panelist Zoobia Chaudhry also had none. Planner disclosures list financial relationships for Peminda Cabandugama and Angela Golden with several pharmaceutical companies and a medical food company.<br /><br />A bibliography cites three references related to obesity management, digital diabetes prevention, and obesity pharmacotherapy in type 2 diabetes. The document ends with a disclaimer stating that the materials are for educational use only, should not replace professional care, and are used at the reader’s own risk. It was last updated on August 5, 2024.

Keywords

obesity management

CME course

The Obesity Society

AMA PRA Category 1 Credit

primary care

learning objectives

ACCME standards

financial disclosures

obesity pharmacotherapy

digital diabetes prevention